ST. PAUL, Minn., Nov. 25, 2013 /PRNewswire/ -- Evergreen Medical Technologies (Saint Paul, Minnesota) and Bose Corporation (Framingham, Massachusetts) have announced a partnership to enhance the testing of medical devices by providing a broad-range of testing capabilities to evaluate the safety of implantable devices. Bose Corporation, through its ElectroForce Systems Group, is a leader in the development and sales of materials characterization and durability test equipment to medical device companies worldwide. Evergreen, through its PhysioTest subsidiary, is a leader in the testing of medical devices as an independent test laboratory for medical device companies worldwide.
"Medical device testing continues to be more and more critical for the benefit of the medical device companies, regulatory agencies, physicians, and patients. The knowledge that PhysioTest and Bose bring in a partnership will be able to enhance testing for companies whether they are large established companies or smaller startup companies," says Randall Nelson, Founder and President of Evergreen Medical Technologies.
Matt Thompson from Bose ElectroForce Group, says, "the partnership between Bose and PhysioTest offers a new level of service by providing advanced development of testing procedures and testing services through PhysioTest, and advanced instruments for medical device testing through Bose. This partnership provides for a continuum of services previously unavailable to medical device developers." According to Thompson, an initial focus will be in the area of implantable leads testing, a top industry priority given the visibility and attention currently directed at this subject.
Nelson says that device testing has become more complex and continues to require repeatable and validatable testing to meet the increasing demands for regulatory science based decisions. With PhysioTest's expertise in the knowledge of medical device testing and Bose's expertise in the development of highly sophisticated and reliable test equipment, the partnership expects to provide better testing capabilities to all medical device companies.
Bose, in collaboration with PhysioTest, will continue to develop new test equipment to meet the increasing demands required by device companies and regulatory authorities. PhysioTest, in collaboration with Bose, will continue to grow its testing capabilities as an independent test facility to conduct testing for smaller companies and to conduct confirmation testing for the larger companies.
PhysioTest is an independent test laboratory for the reliability and durability testing of critical medical devices. The company conducts tests for companies during device development, for submission to regulatory authorities (Design Verification Testing), and throughout the market cycle of a device. PhysioTest also develops tests to verify unique device requirements that a company may have. PhysioTest will also work with device companies to determine appropriate tests for their devices. PhysioTest, LLC is a wholly owned subsidiary of Evergreen Medical Technologies, Inc. For the latest news and information about Evergreen, visit http://www.evergreenmedtech.com, call 651.646.7700, or e-mail email@example.com.
About Bose Corporation, ElectroForce Group
Bose Corporation's ElectroForce Systems Group develops advanced instruments for accelerated fatigue and durability testing of medical devices and components such as vascular stents, electrical leads and heart valve replacements, as well as instruments for characterization of materials used in the development of medical devices. Bose Test Systems are used around the world to test medical devices and components during the product development process and for regulatory submission. Bose Test Systems use patented Bose technology to provide industry-leading performance and reliability. For more information about ElectroForce Systems, visit http://www.bose-electroforce.com or call 952-278-3070.
For Evergreen Medical Technologies:
Randy Nelson • 651.646.7701
For Bose Corporation:
Matt Thompson • 952.278.3070
|SOURCE Evergreen Medical Technologies|
Copyright©2012 PR Newswire.
All rights reserved